Conflicts of Interest
R.Q.C. reports speaker fees, consulting fees, and grant support from Sobi, consulting fees from Sironax and Novartis, speaker fees from Lilly, and clinical trial side-effect adjudication committee work support from Pfizer. T.B. has received consulting fees from Novartis and UCB. W.W.C. reports consulting fees and grant support from SOBI. The other authors declare no conflicts of interest.